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A B S T R A C T The presence of circulating immune
complexes (IC) in patients with infective endocarditis
has been well documented but the contributions of
host and bacterial components to these IC have not
been defined. To study this question, IC were isolated
from serum of a patient with Streptococcus faecalis
endocarditis by differential polyethylene glycol pre-
cipitation and competitive binding to staphylococcal
protein A. A rabbit antiserum raised against the pu-
rified IC had reactivity by crossed immunoelectro-
phoresis primarily with an antigen derived from the
cytoplasm of the infective organism. The antigen was
a protein with a 12,000-dalton molecular mass. In situ
radiolabeling of the IC bound to the protein A dem-
onstrated a component of the same molecular mass as
the bacterial antigen recognized by the antiserum. The
patient serum had multiple antibody specificities re-
active with bacterial antigens, including the antigen
recognized by the rabbit anti-IC antiserum. These
techniques for isolation and characterization of cir-
culating IC may have value in the study of IC diseases
in which the inciting antigens are not known.
INTRODUCTION
Infective endocarditis (IE)l is a clinical model for the
study of the hyperimmune state in which the antigenic
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'Abbreviations used in this paper: Az, azide; BSA, bovine
serum albumin; CDM, chemically defined medium; IC, im-
mune complexes; IE, infective endocarditis; LPO, lactoper-
oxidase; NHS, normal human serum; PBS, phosphate-buff-
ered saline; PEG, polyethylene glycol; SDS-PAGE, sodium
dodecyl sulfate-polyacrylamide gel electrophoresis; Staph A,
Staphylococcus aureus; XIE, crossed immunoelectropho-
resis.
stimulus is known. Localization of IgG (1) and bac-
terial antigens (2) in glomeruli have implicated im-
mune complexes (IC) in the pathogenesis of the glo-
merulonephritis associated with IE, but it has not been
resolved whether such extracardiac manifestations of
the disease derive from in situ formation or from de-
position of circulating IC. Circulating IC have been
documented in IE by several methods, using cryopre-
cipitation (3), polyethylene glycol (PEG) precipitation
and Clq binding (4), and binding to Raji cells (5), but
the relationship of the IC to exogenous vs. endogenous
antigens of the host has not been clarified. Autoim-
mune reactants including antigammaglobulins (6-8)
could be involved in IC formation, although no cor-
relation was observed in one study between IC levels
in patients with IE and the amount of rheumatoid
factors measured by radioimmunoassay (9). Autoan-
tibodies to other endogenous antigens (10) might also
contribute to IC formation. The present study was
undertaken to address the role of bacterial antigens in
the formation of circulating IC in IE.
METHODS
Reagents and buffers. Rabbit IgG was obtained from
Pentex Biochemical, Kankakee, IL. Polyethylene glycol
(PEG, 6,000 mol wt; J. T. Baker Chemical Co., Phillipsburg,
NJ) was dissolved in borate saline buffer (0.1 Mboric acid,
0.25 M sodium tetraborate, 0.75 M NaCl, pH 8.3) at a 15%
wt/vol stock solution and further diluted in the same buffer.
EDTAbuffer consisted of 0.2 Mdisodium EDTA, adjusted
to pH 7.5 with 1 N NaOH. Phosphate-buffered saline with
sodium azide (PBS-Az) was 0.01 Mphosphate, 0.15 MNaCl,
0.1% Az, pH 7.2. Bovine serum albumin (BSA, Pentex Bio-
chemical) was added to PBS-Az at 0.5% wt/vol and the pH
adjusted to 7.2-7.4 with 1 N NaOH. Pansorbin (Calbiochem-
Behring Corp., American Hoechst Corp., San Diego, CA)
was used as a source of protein-A-bearing Staphylococcus
aureus (Staph A). Trypsin was obtained from Sigma Chem-
ical Co., St. Louis, MOand was combined with the selected
substrate at a ratio of 1 mg trypsin/100 mg substrate for a
48-h incubation at 37°C. Sepharose-bound protein A was
obtained from Pharmacia Fine Chemicals, Piscataway, NJ.
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FIGURE 1 Immunoelectrophoresis assessing reactivity of rabbit anti-IC antiserum with NHS.
Well contains NHS. Upper trough contains rabbit anti-NHS antiserum. Lower trough contains
anti-IC antiserum. Anode is to the right.
Serum. Blood was allowed to clot at room temperature
for 1-2 h. Serum was removed by centrifugation and stored
at -70°C in 0.4-ml aliquots. Serum samples were thawed
FIGURE 2 Rocket immunoelectrophoresis. Wells contain sol-
uble preparation of S. faecalis cytoplasm, at concentrations
of 0.66 mg/ml (left) and 0.16 mg/ml. Gel contains 0.4 ml
of rabbit anti-IC antiserum.
just before assay and used only once. Serial blood samples
during the course of antibiotic therapy were obtained from
a patient (H.S.) with IE (Streptococcusfaecalis). The patient
was selected for study because of high levels of circulating
IC, as measured by the Staph A binding assay.
FIGURE 3 XIE. Well contains soluble preparation of S. fae-
calis cytoplasm, 5 mg/ml. Gel for second dimension elec-
trophoresis contains 0.4 ml of rabbit anti-IC antiserum.
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FIGURE 4 XIE. Well contains soluble preparation of S. faecalis cytoplasm, 5 mg/ml. Gel for
second dimension electrophoresis contains 0.4 ml of serum from patient H.S., with S. faecalis
endocarditis.
Isolation of IC. A modification of the Staph A binding
assay (11) was used for isolation of IC. To 10 X 75-mm plastic
tubes (Falcon Labware, Div. of Becton, Dickinson & Co.,
Oxnard, CA) was added 300 ,ul EDTAbuffer, 100 Al of test
serum, and 2.0 ml 6% PEG. The tubes were incubated over-
night at 4°C and centrifuged at 1,000 g for 20 min. The
supernate was aspirated and the pellet was resuspended in
5% PGE, and centrifuged again. The supernate was aspi-
rated, and the pellet was suspended in 200 ,ul PBS-Az and
allowed to sit at room temperature for 20 min with agitation
to dissolve the precipitate. 100 gl of the solubilized precip-
itate was transferred to a 10 X 75-mm tube that was pre-
rinsed with PBS-BSA-Az and contained 100 Ml of a 0.8% vol/
vol suspension of Staph A in PBS-BSA-Az. After incubation
in a 370C water bath for 2 h, 1.0 ml of PBS-BSA-Az was
added and the tubes centrifuged at 1,000 g for 10 min. The
supernate was aspirated, and the pellet was resuspended in
1.0 ml PBS-Az containing 5 mg/ml rabbit IgG. After another
2-h incubation at 37°C with frequent agitation, the tubes
were centrifuged at 1,000 g for 20 min. The Staph A pellets
were washed two times by centrifugation with 2 ml PBS-Az,
then 200 ul of either 3 M NaSCN or 1% sodium dodecyl
sulfate (SDS) were added to the tubes. Previous studies
showed comparable recovery of IC using these eluants (12).
After incubation at 37°C for 30 min with frequent agitation,
tubes were centrifuged at 1,000 g for 20 min and the su-
pernate aspirated. The NaSCNeluates were dialyzed against
PBS before use. The SDS eluates were used in SDS-poly-
acrylamide gel electrophoresis (SDS-PAGE) without further
modification.
Immunization with IC. Preimmune sera were taken
from rabbits before starting the immunization procedures.
The material eluted from the Staph A with 3 MNaSCNwas
emulsified with equal volumes of complete Freund's adju-
vant. This was used for immunization of rabbits by subcu-
taneous inoculation using 0.4 ml of immunogen per rabbit
on each occasion. After the initial immunization, there were
two booster injections 2 and 3 wk later. A control immuni-
zation used a NaSCNeluate from Staph A alone.
Surface radiolabeling of IC. The procedure outlined
above for isolation of IC was carried out to completion of
Staph A washing after incubation with rabbit IgG. PBS,
rather than PBS-Az, was used for washes to avoid interfer-
ence with the radiolabeling procedure. The Staph A-bound
IC were radiolabeled by the lactoperoxidase (LPO) method
(13) as follows. To the tubes containing the washed Staph
A pellets were added 20 Mg of LPO (Calbiochem-Behring
Corp.), 250 MCi of Na251I (Amersham Corp., Arlington
Heights, IL), and 10 Ml of H202. These were incubated with
gentle agitation for 30 min, then the reaction was stopped
with 0.5 ml PBS-Az. The radiolabeled IC were then eluted
from the Staph A with either 3 M NaSCN or 1% SDS as
described above. Control labeling of Staph A alone, without
addition of serum or IgG, was performed concurrently.
Isolation and culturing of bacteria. S. faecalis isolated
from the patient's blood was cultured on a blood agar plate.
Colonies from the plate were removed with loops for inoc-
ulation of 250 ml of Todd-Hewitt broth (Difco Laboratories,
Detroit, MI), and incubated overnight at 37°C. The culture
was centrifuged at 1,000 g for 20 min and the supernatant
aspirated. The pellet was resuspended in 5 ml Todd-Hewitt
broth and stored at -70°C in 0.3-ml lots. A 1% inoculation
of bacteria from the frozen stock concentrate (50 Ml) was
removed to inoculate 5 ml of chemically defined medium
(CDM), as developed by van de Rijn and Kessler (14).
Growth of bacteria was monitored by optical density and
when bacteria were in their log growth phase, 500 ml of
CDMwas inoculated with the 5 ml subculture. This was
incubated overnight at 37°C.
Fractionation of bacteria. - These methods have been de-
scribed in detail previously (15, 16). Briefly, extracellular
products were obtained by filtration of the CDMmedium
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FIGURE 5 XIE. Well contains soluble preparation of S. faecalis cytoplasm, 5 mg/ml. Gel for
second dimension electrophoresis contains 0.4 ml of serum from patient R.D. with S. faecalis
endocarditis.
using an Amicon DM10 filter (Amicon Corp., Lexington,
MA). Bacteria were broken by glass bead disintegration (15)
in a vibrogen cell mill (Rho Scientific, Commack, NY). Dif-
ferential centrifugations were then used to separate cell wall,
cell membrane, and cytoplasm. For detergent extraction of
cell wall and membrane, 10 mg of material was added to
1 ml of 4% Triton X-100 (in 0.5 M Tris-HCl, pH 8.9) and
incubated at 37°C for 4 h with stirring. After centrifugation
(30,000 g for 10 min) the supernatant was removed for anal-
ysis. Acid extraction of the cell wall was performed by add-
ing 0.5 ml 0.2 N HCI to 10 mg cell wall. This was placed
in a boiling water bath for 5 min, cooled on ice, and neu-
tralized to pH 7.0 with 1 N NaOH. After centrifugation
(1,000 g for 10 min) the supernatant was removed for study.
Immunological methods. Reactivity of rabbit antiserum
was examined by double diffusion in agar plates and by
immunoelectrophoresis. Rocket electrophoresis was per-
formed as previously described (17). Crossed immunoelec-
trophoresis (XIE) was performed on glass plates (50 X 50
X 0.6 mm) using 1% agarose gels prepared from Seakem
HGT(Marine Colloids, Inc., Rockland, ME) (18, 19). Elec-
trophoresis was carried out at 5 V/cm for 60 min using a
Pharmacia flat bed (Pharmacia Inc.) and a Lauda cooling
system. After electrophoresis, an agarose strip (10 X 50 mm)
containing the separated antigens was retained on each plate
while the rest of the gel was removed and replaced with 1%
agarose containing either rabbit antiserum or patient serum.
Electrophoresis was then carried out perpendicular to the
original direction at 2 V/cm for 16-20 h. Gels were alter-
nately pressed and washed three times with 0.1 M NaCl.
After a final press, they were briefly rinsed with a stream
of distilled water and dried with a hair dryer before staining
with Coomassie Brilliant Blue R-250.
Adsorption of antigen from bacterial cytoplasm. The
IgG fraction of the rabbit antiserum was obtained by DEAE
cellulose chromatography (DE-52, Whatman Ltd., Maid-





stone, Kent, England). DE-52 and the antiserum were equil-
ibrated with 0.02 Mphosphate buffer, pH 8.0. Material not
retained on the column was made 0.15 M in NaCl. Rabbit
IgG for control adsorption was obtained from Pentex Bio-
chemical. The IgG preparations were coupled to cyanogen
bromide-activated Sepharose 4B (20). A 66% vol/vol slurry
(0.3 ml) of each Sepharose preparation in PBSwas incubated
with 0.05 ml of the cytoplasm preparation of S. faecalis.
Adsorption was carried out at room temperature for 30 min
followed by centrifugation at 1,000 g for 30 min. The su-
pernates were aspirated and run in XIE against the rabbit
antiserum and against the patient's serum.
SDS-PAGE. Components were analyzed by SDS-PAGE
by methods previously described (21). For these studies, IC
were eluted from the Staph A by incubation with 1% SDS
for 30 min at 30°C. The eluate was combined with an equal
volume of the following: 0.1 M Tris, 0.0015 MEDTA, 20%
glycerol, 2% SDS, and 0.1 mg/ml bromphenol blue, pH 7.5.
This mixture was placed in boiling water for 2 min then
applied to either a 5 or 7.5% polyacrylamide gel. In certain
cases 20 gl of 2-mercaptoethanol were combined with the
eluate before SDS-PAGE. Electrophoresis was carried out
at 100 V for 90 min in a buffer of 0.1 M phosphate, 0.2%
SDS, pH 7.2. The 10-cm gels were sliced into 1-mm fractions
in a Gilson gel slicer (Gilson Co., Inc., Worthington, OH)
and the fractions counted in a gammacounter. For molecular
mass determination the following controls were electropho-
resed concurrently: ribonuclease A (13,700 daltons), cyto-
chrome c (12,400 daltons), chymotrypsinogen (25,000 dal-
tons), and ovalbumin (45,000 daltons).
RESULTS
Rabbit antiserum reactivity with human serum.
Ouchterlony double-diffusion analysis confirmed reac-
tivity of the rabbit antiserum with normal human
serum (NHS). Immunoelectrophoresis showed that this
reactivity with NHSwas confined almost exclusively
to IgG (Fig. 1) with slight reactivity with IgM, as con-
firmed by lines of identity in Ouchterlony plates using
IgG and IgM. The control rabbit immunized with the
eluate from Staph A alone showed no reactivity
with NHS.
Rabbit antiserum reactivity with bacterial compo-
nents. Using Laurell rocket electrophoresis, the main
reactivity of the antiserum was with the antigenic
preparation derived from the bacterial cytoplasm (Fig.
2). Reactivity could be demonstrated with a 0.05 mg/
ml concentration of the cytoplasm. A lower degree of
reactivity was present with the acid extract of the bac-
terial cell wall, with no precipitate seen at concentra-
tions <6.0 mg/ml. There was no reactivity of the an-
tiserum with the bacterial extracellular products, the
detergent extract of the cell wall, nor with the bacterial
membrane. Preimmune serum and antiserum from
rabbits immunized with Staph A alone did not react
with any streptococcal components.
XIE (Fig. 3) showed that there was a single antigen
in the cytoplasmic preparation with which the anti-
serum reacted. The immunoprecipitate in XIE was
eliminated by prior incubation of the antigen with
trypsin. The single precipitate seen when the cyto-
plasm was electrophoresed into the rabbit antiserum
was contrasted with the XIE pattern seen when the
FIGURE 6 XIE. Well contains soluble preparation of S. faecalis cytoplasm, 5 mg/ml. Gel for
second dimension electrophoresis contains 0.4 ml of serum from a patient with S. faecium
endocarditis.
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FIGURE 7 Rocket immunoelectrophoresis. (a) Precipitate (left well) and supernatant (right
well) following addition of 5% PEGto NHS. (b) Precipitate (left well) and supernatant (right
well) after addition of 5% PEGto NHSincubated with S. faecalis cytoplasm. (c) S. faecalis
cytoplasm. In each case gel contains 0.4 ul rabbit anti-IC antiserum.
cytoplasm reacted with the patient's serum under the
same conditions (Fig. 4). In the latter there were sev-
eral precipitates observed. For comparison, the cyto-
plasmic preparation was electrophoresed into the
serum of another patient (R.D.) with S. faecalis IE
(Fig. 5). This patient's serum also recognized several
antigenic determinants in the cytoplasm of the bac-
terium, although the patterns appeared distinct from
the first patient, both in electrophoretic mobility of
the antigens and shape of the immunoprecipitates.
Serum from a patient with Streptococcus faecium IE,
a closely related group D streptococcus, also showed
reactivity with the cytoplasm of S. faecalis, but with
fewer specificities (Fig. 6). Sera from IE patients in-
fected with the following organisms were all negative
for reactivity with S. faecalis antigens: Streptococcus
mitior, Streptococcus bovis, Staphylococcus aureus,
Candida albicans.
PEGprecipitation of antigen. To exclude the pos-
sibility that the rabbit was immunized with free, un-
complexed antigen derived from the patient's serum,
a study using PEGprecipitation was performed. Using
the 5% PEG for the isolation of the IC, it was dem-
onstrated that the PEGprecipitate of the purified bac-
terial cytoplasm did not show reactivity with the rabbit
anti-IC antiserum, whereas the supernatant did. When
the bacterial cytoplasm was incubated with NHS, then
the PEGprecipitation carried out, once again only the
supernatant showed reactivity with the rabbit antise-
rum (Fig. 7). The presence of the antigen in the Staph
A eluate used for immunization indicates that the an-
tigen in the patient serum was precipitated by 5% PEG
and suggests that it was bound specifically to immu-
noglobulin.
Molecular mass determination of bacterial cyto-
plasmic antigen. Exogenous radiolabeling of the cy-




toplasmic preparation with "25I was performed by the
LPO method. The preparation was electrophoresed in
XIE using rabbit antiserum as described above. After
pressing and staining, the immunoprecipitates were
excised, placed in a test tube containing 200 ul 1%
SDS, 0.5 MNaHCO3, bromphenol blue, and glycerol.
This was placed in boiling water for 2 min, then trans-
ferred to SDS-PAGE. Molecular mass was derived
from comparison with known molecular mass markers
electrophoresed in the same run under identical con-
ditions. The main peak of activity indicated a com-
ponent of 12,000 daltons, with a second peak at 24,000
daltons (Fig. 8). The absence of 2-mercaptoethanol in
the SDS-PAGEresulted in no change in this two-peak
pattern.
Surface labeling of Staph A-bound IC. Confir-
mation of the excised rocket analysis was sought by
comparing these results with those obtained by in situ
radiolabeling of the patient IC bound to the Staph A.
Surface labeling of the Staph A-bound IC (Fig. 9) il-
lustrates on SDS-PAGE a 12,000-dalton component.
The presence of a 24,000-dalton peak could not be
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FIGURE 8 7.5% SDS. PAGE(with 20 ul 2-mercaptoethanol)
of excised immunoprecipitate derived from XIE of radio-
labeled S. faecalis cytoplasm electrophoresed into agar con-
taining rabbit anti-IC antiserum. Top of gel to the right.
Peaks correspond to molecular mass of 12,000 and 24,000
daltons.
chain of IgG peak, which is labeled and eluted con-
comitantly with the antigen. Control labeling experi-
ments of Staph A alone (Fig. lOa) and Sepharose-pro-
tein A (Fig. lOb) indicated that the labeling and elution
procedures yielded protein A from the staphylococcal
surface as a predictable background phenomenon. The
recombination of dissociated components of the sur-
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FIGURE 9 7.5% SDS. PAGE(with 20 1d 2-mercaptoethanol)
of patient IC radiolabeled in situ on surface of Staph A
labeled IC eluted with 2% SDS (Methods). Top of gel to the
right. Major peaks correspond to molecular mass of 12,000,
24,000, and 51,000 daltons. H and L designate positions of
heavy and light chains of IgG electrophoresed under the
same conditions.
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FIGURE 10 7.5% SDS. PAGE(with 20 gl 2-mercaptoethanol). (a) Surface labeling of Staph A
by LPO method, with subsequent elution by 2% SDS. (b) Surface labeling of Sepharose-protein
A LPO method, with elution by 2% SDS.
itively. The cycle of elution, dissociation and reasso-
ciation of antigen and antibody moieties might result
in denaturing effects on each component. The identity
of the 12,000-dalton component defined by the anti-
IC antiserum reacting with bacterial products (Fig. 8)
and the 12,000-dalton component defined by surface-
labeling of IC (Fig. 9) remains presumptive only.
DISCUSSION
It has remained a controversial issue whether the
pathogenesis of the extracardiac manifestations of IE
results primarily from septic microemboli or circulat-
ing IC. The observations of hypocomplementemia and
glomerular deposits of IgG and complement (1) by
immunofluorescence provided indirect support for the
latter. Although immunoglobulins eluted from glo-
meruli have been shown to have reactivity with bac-
teria (22), recent studies in experimental IE have con-
tinued to implicate septic emboli as the initiating event
in renal inflammation (23). Several reports have now
documented circulating IC in patients with IE. Serum
cryoglobulins were found in 19 of 20 patients with IE,
and the concentration of the cryoglobulins tended to
fall with therapy and clinical improvement of the pa-
tients (3). Using a PEGprecipitation assay and the Clq
binding assay, circulating IC were found in 84% of
patients with IE (4). Bayer et al. (5) found elevated
serum levels of IC by the Raji cell assay and noted a
positive correlation of IC levels with duration of illness,
extravalvular manifestations of IE, and hypocomple-
mentemia. Whether the antigens in these circulating
IC are of microbial or host origin is unresolved. A
previous study on PEG precipitates in IE failed to
demonstrate bacterial antigen or host antibody di-
rected against bacteria (24), although some investi-
gators have found evidence implicating bacterial an-
tigens during the course of Staph A bacteriemia (25).
Our recent studies using binding to Staph A for char-
acterization of IC in patients with hepatitis B systemic
vasculitis (12) led us to further develop this method-
ology for the study of IC in patients with IE.
A patient with IE due to S. faecalis was found to
have increased levels of circulating IC by the Staph
A binding assay. By the use of PEGprecipitation and
binding to Staph A to isolate the IC from the patient's
serum, we raised an antibody in rabbits against the IC.
Successful immunization of the rabbit by the immu-
noglobulin moiety of the IC was confirmed by im-
munoelectrophoresis. To search for bacterial antigens
278 Inman, Redecha, Knechtle, Schned, van de Rijn, and Christian
16 a
within the IC, S. faecalis isolated from the patient's
blood was cultured and fractionated into constituent
parts. The organism was cultured in a CDMso that
the reactivity with bacterial antigens could be assessed
in conditions free of contamination by serum. XIE in-
dicated that the predominant reactivity of the rabbit
antiserum was against a protein derived from the bac-
terial cytoplasm. The molecular mass of this compo-
nent, as measured by SDS-PAGE, was 12,000 daltons.
A component of 24,000 daltons was also observed on
SDS-PAGE, suggesting the possibility of a dimeric
form of the lower molecular mass component or a sec-
ond antigen.
The possibility that the rabbit had been immunized
with free antigen from patient serum was minimized
by the finding that the antigen either alone or when
incubated with NHS was not precipitable in the 5%
PEGused for isolation of the IC. The finding of a small
amount of reactivity of the rabbit antiserum with a
bacterial cell wall component indicated that the
circulating IC in the patient's serum likely were het-
erogeneous, containing at least two different antigen-
antibody systems. The possibility exists that immuni-
zation of additional animals might have revealed
additional bacterial products contributing to IC for-
mation. The persistence of IC for a prolonged period
after the patient's blood cultures became sterile and
the sustained immune response to bacterial antigens
suggests that some of the delayed manifestations of IE
may be secondary to the host immune response to sol-
uble products of bacteria rather than peripheral de-
position of viable organisms.
Although the patient had demonstrable antibodies
against several bacterial antigens, the IC studied sug-
gested that only a select few of these antigen-antibody
systems were represented in the population of circu-
lating IC. It may be that the other antigen-antibody
systems in the patient serum were not represented in
our analyzed IC because the IC of these alternative
specificities were rapidly cleared from the patient's
circulation by the monocyte-macrophage system. Al-
ternatively, the sampling of blood may have occurred
at a time of marked antibody excess, when these an-
tigens were present only in trace amounts. It is also
possible that the two antigens detected were more im-
munogenic than the others. Even with the same in-
fecting organism the patterns of antibodies elicited by
different patients can be quite dissimilar, as was ob-
served in the XIE pattern of two patients' serum
against the cytoplasm of S. faecalis. The value of the
rabbit antiserum in these analyses was as an immu-
nospecific probe with reactivity restricted to those an-
tigens involved in IC formation, in contradistinction
to the patient serum that revealed multiple reactivities
against a variety of antigens. The observation that
multiple immunoreactivities of patients' sera, as de-
tected by XIE, were sustained for a prolonged period
after institution of antimicrobial therapy implies a
continuing immunogenic stimulus by bacterial anti-
gens that could be involved in IC-mediated injury at
varied levels and at different stages of disease.
In two clinical models of IC disease where etiological
factors are known (hepatitis B virus-related vasculitis
and IE) the techniques herein described have dem-
onstrated microbial antigens in purified IC. On the
basis of this experience, comparable methods of study
may lead to the identification and characterization of
antigens involved in IC formation in diseases of un-
known etiology.
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